Investors

Meet Our Valuable Investors

Financial Results

FY 2021-2022

Audited Standalone Financial Statements for 31.03.2022

FY 2022 - 2023

Audited Standalone Financial Statements for 31.03.2023

Audited Consolidated Financial Statements for 31.03.2023

FY 2023-2024

Audited Standalone and Consolidated Financial Results for quarter ended 30.06.2023

Audited Standalone and Consolidated Financial Results for quarter ended 30.09.2023

Audited Standalone and Consolidated Financial Results for quarter ended 31.12.2023

Audited Standalone and Consolidated Financial Results for quarter and year ended 31.03.2024

Notice of Board Meetings

FY 2023-2024

Notice for the quarter ended September 30, 2023

Notice for the quarter ended December 31, 2023

Notice for the quarter and year ended March 31, 2024

Postal Ballot

2023-24

Postal Ballot Notice

Newspaper Publication

E Voting Results and Scrutinizer's Report

Annual Report

FY 2021-2022

  Annual Report 2022

FY 2022-2023

 Annual Report 2023

FY 2023-2024

Annual Report 2024

Policies

Details of Business


Terms and Conditions of appointment of Independent Directors

Composition of Various Committees

Code of Conduct of Board of Directors and Senior Management personnel

Code of Conduct for Independent Director

Whistle Blower Policy

Nomination and Remuneration Policy

Policy on dealing with Related Party Transactions


Policy for determining Material Subsidiaries

Details of Familiarization programme

Code of Conduct for prevention of Insider Trading in securities of the Company

Risk Management Policy

Succession Policy

Policy on determination of materiality of event

Preservation and Archival

Prevention of Sexual Harassment at Workplace

Cyber Security Policy

CSR Policy

Human Rights Policy

Dividend Distribution Policy

Criteria for Board Evaluation

Policy for enquiry in case of leak of UPSI

Policy on Diversity of the Board

Shareholding Pattern

FY 2023-2024

Shareholding Pattern as on 30-09-2023

Shareholding Pattern as on 31-12-2023

Shareholding Pattern as on 31-03-2024

Corporate Governance

FY 2023-2024

Corporate Governance Report for the quarter ended 31-12-2023

Corporate Governance Report for the quarter ended 31-03-2024

Audited Financial Statements of Subsidiaries

FY 2022-2023

Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for year ended 31.03.2023

FY 2023-2024

Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for quarter ended 30.06.2023

Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for quarter ended 30.09.2023

Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for quarter ended 31.12.2023

Audited Standalone Financial Statements of Valiant Advanced Sciences Pvt Ltd for year ended 31.03.2024

Closure of Trading Window

FY 2023-2024

Intimation of Closure of Trading window_06.10.2023

Intimation of Closure of Trading window_31.12.2023

Intimation of Closure of Trading window_31.03.2024

FY 2024-25

Intimation of Closure of Trading window_30.06.2024

Newspaper Publication of Financial Results

FY 2023 - 2024

Audited Standalone and Consolidated Financials for quarter ended 30-09-2023

Audited Standalone and Consolidated Financials for quarter ended 31-12-2023

Audited Standalone and Consolidated Financials for quarter and year ended 31-03-2024

Initial Public Offer

Prospectus

Red Herring Prospectus

Draft Red Herring Prospectus

Restated Financials: Standalone Audit Report

Standalone Financial Statements

Consolidated Audit Report

Consolidated Financial Statements

CRISIL Industry Report

Consent Letters

Key Performance Indicators

Chartered Engineers Certificate

Working Capital Assessment

Statement of Tax Benefits

Agreements

Monitoring Agency Agreement

Agreement with RTA

Escrow and Sponsor Bank Agreement

Syndicate Agreement

Tripartite Agreement  with CDSL

Tripartite Agreement  with NSDL

Shareholders agreement

Amendment to Shareholders agreement

Issue Agreement

Approval of Red Herring Prospectus

CRISIL Industry Report

SEBI Letter dated June 28, 2023

SEBI letter dated September 12, 2023

Due Diligence Certificate

Regulation wise Checklist

Approvals Sought

Board Approval for issue of Shares dated 30-01-2023

Shareholders approval for Issue of Shares dated 20-03-2023

Boards approval for approving objects of the issue dated 23-05-2023

Board's approval for Draft Red herring Prospectus dated 05-06-2023

Board's approval for Red Herring Prospectus dated 18-09-2023

In - Principle approval of NSE dated 25-08-2023

In - Principle approval of BSE dated 25-08-2023

Credit Ratings

Credit Rating dated 27-11-2023


Credit Rating dated 21-02-2024

Credit Rating dated 06-04-2024

Disclosures on Stock Exchange

Intimation of the Acquisition

Resignation of Company Secretary

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended March 31,2024

Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended December 31,2023

Certificate under Regulation 7(3) of SEBI LODR for year ended March 31, 2024

Certificate under Regulation 40(9) of SEBI (LODR) for year ended March 31, 2024

Annual Secretarial Compliance Report for the year ended March 31, 2024

Monitoring Agency Report

For the Quarter ended on 31-12-2023

For the Quarter ended on 31-03-2024

Statement of Deviation and Variation

For the Quarter ended on 31-12-2023

For the Quarter ended on 31-03-2024

Annual Return

Downloads

Form No. SH-14

Form ISR - 2

Form ISR - 1

Form ISR - 3

Form No. SH-13

Form ISR - 4

Annual General Meetings

2023-24

Newspaper Publication (Pre -AGM)

Contact Information

Determining Materiality

Pursuant to regulation 30(5) of the SEBI (Listing Obligation & Disclosure Requirements), Regulations 2015,the following are “severally” authorized for the purpose of determining materiality of an event or information and for the purpose of making disclosures to Stock Exchanges (s). :

Shareholder Grievance and Nodal Officer

Pursuant to regulation 46(2) (j) (k) of the SEBI (Listing Obligation & Disclosure Requirements), Regulations 2015, the investors may contact the below mentioned email id for the purpose of Registering Complaints:
Registrar and Share Transfer Agent

Mr. Santosh Vora

Managing Director

022 – 49712001 / 49717220

investor@valiantlabs.in

104, Udyog Kshetra | First Floor, Mulund Goregaon Link Road, Mulund (W) – 400080

Ms. Prajakta Patil

Company Secretary & Compliance Officer

022 – 49712001 / 49717220

investor@valiantlabs.in

104, Udyog Kshetra | First Floor, Mulund Goregaon Link Road, Mulund (W) – 400080

Unit: Valiant Laboratories Limited

Address : C-101, 247 Park, L.B.S Marg,
Vikhroli (W), Mumbai – 400083, Maharashtra.

Contact Number : +91 22 4918 6000

Fax Number : +91 22 4918 6060

Email IDrnt.helpdesk@linkintime.co.in

Websitehttp://linkintime.co.in